Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines

被引:0
|
作者
Greenberg, P
机构
[1] Stanford Univ, Med Ctr, Div Haematol, Palo Alto, CA 94305 USA
[2] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:III41 / III42
页数:2
相关论文
共 50 条
  • [1] WILL CYTOKINES ALTER THE TREATMENT OF MYELODYSPLASTIC SYNDROME
    SCHUSTER, MW
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 305 (02): : 72 - 78
  • [2] Development of oral demethylating agents for the treatment of myelodysplastic syndrome
    Ziemba, Amy
    Ramirez, Marcela Cortes
    Freeman, Burgess
    Hayes, Eugene
    Ye, Tao
    Pizzorno, Giuseppe
    [J]. CANCER RESEARCH, 2009, 69
  • [3] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
  • [4] Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome
    Ishikawa, Takayuki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 10 - 15
  • [6] Predictive Factors of Treatment Response to Hypomethylating Agents in Patients with Myelodysplastic Syndrome
    Wu, Ping
    Du, Xin
    Weng, Jianyu
    Deng, Chengxin
    Geng, Suxia
    Lu, Zesheng
    Lai, Peilong
    Huang, Xin
    Luo, Chengwei
    [J]. BLOOD, 2015, 126 (23)
  • [7] Activity of Hypomethylating Agents in the Treatment of Therapy-Related Myelodysplastic Syndrome
    Pierola, Ana Alfonso
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Feng Wang
    Song Xingzhi
    Jabbour, Elias J.
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    DiNardo, Courtney D.
    Daver, Naval G.
    Borthakur, Gautam
    Pemmaraju, Naveen
    Konopleva, Marina
    Bueso-Ramos, Carlos E.
    Patel, Keyur
    Futreal, Andrew
    Pierce, Sherry
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    [J]. BLOOD, 2016, 128 (22)
  • [8] Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome
    Takayuki Ishikawa
    [J]. International Journal of Clinical Oncology, 2014, 19 : 10 - 15
  • [9] TREATMENT OF THE MYELODYSPLASTIC SYNDROME
    AUL, C
    HEYLL, A
    GATTERMANN, N
    SCHNEIDER, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (08) : 309 - 313
  • [10] TREATMENT OF THE MYELODYSPLASTIC SYNDROME
    AUL, C
    HEYLL, A
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (48) : 1842 - 1850